Cytochrome c (cyt c), required for electron transport in mitochondria, possesses a covalently attached heme cofactor. Attachment is catalyzed by holocytochrome c synthase (HCCS), leading to two thioether bonds between heme and a conserved CXXCH motif of cyt c. In cyt c, histidine (His19) of CXXCH acts as an axial ligand to heme iron and upon release of holocytochrome c from HCCS, folding leads to formation of a second axial interaction with methionine (Met81). We previously discovered mutations in human HCCS that facilitate increased biosynthesis of cyt c in recombinant Escherichia coli. Focusing on HCCS E159A, novel cyt c variants in quantities that are sufficient for biophysical analysis are biosynthesized. Cyt c H19M, the first bis-Met liganded cyt c, is compared with other axial ligand variants (M81A, M81H) and single thioether cyt c variants. For variants with axial ligand substitutions, electronic absorption, near-UV circular dichroism, and electron paramagnetic resonance spectroscopy provide evidence that axial ligands are changed and the heme environment is altered. Circular dichroism spectra in far UV and thermal denaturation analyses demonstrate that axial ligand changes do not affect secondary structures and stability. Redox potentials span a 400-mV range (+349 mV vs. standard hydrogen electrode, H19M; +252 mV, WT; −19 mV, M81A; −69 mV, M81H). We discuss the results in the context of a four-step mechanism for HCCS, whereby HCCS mutants such as E159A are enhanced in release (step 4) of cyt c from the HCCS active site; thus, we term these "release mutants." cytochrome c | HCCS | heme | spectroscopy | axial ligands T he mitochondrial monoheme cytochrome c (cyt c) is one of the most studied proteins with respect to its structure, function, and folding. Cyt c is unique because it possesses two covalent thioether bonds between the vinyl groups of heme and two thiols of the protein, at a conserved CXXCH motif. The histidine of CXXCH acts as an axial ligand to heme iron in all cyt c proteins. Thioether attachment is catalyzed by a single enzyme called holocytochrome c synthase (HCCS), which functions in the mitochondrial intermembrane space (1, 2) . Results from biochemical studies on human HCCS and cyt c, functionally expressed in recombinant Escherichia coli, have led to the proposal of a fourstep model for biosynthesis by HCCS ( Fig. 1 ) (3) (4) (5) (6) .
Step 1 entails the binding of heme; certain HCCS mutants are defective in this step (5) , including the E159K substitution that is responsible for micropthalmia with linear skin syndrome (MLS) (HCCS sequence in Fig. S1A , numbering from human HCCS). Another HCCS mutant in step 1, H154A, is unable to bind heme, but is corrected for in vivo function by exogenous imidazole (4) . Spectroscopy and mutagenesis studies also established HCCS His154 as an axial ligand for heme binding. In step 2, apocyt c binds to holoHCCS, with histidine (His-19) of CXXCH providing the second axial ligand in this complex (6) .
Step 3 is formation of the two thioether bonds, which distorts the heme, weakening interaction with the HCCS (6) . This distortion in part promotes step 4, release of holocyt c from HCCS, before cyt c folding. A previous study by Babbitt et al. has speculated that certain HCCS substitutions affect release step 4 ( Fig. 1) (5) . These HCCS mutants appear to enhance release of cyt c, biosynthesizing 1.5-to 2-fold more cyt c (than WT HCCS), and they also copurify with less cyt c than the WT HCCS.
Thus, these are lower in steady-state levels of HCCS/cyt c complex (Fig. 1, steps 2 and 3 ) but yield higher levels of released and folded cyt c product.
Evidence suggests there is a balance in requirements for heme binding by HCCS in step 1 and need for heme release in step 4 (as holocyt c). Studies on HCCS E159 substitutions, the MLS residue, provide some of this evidence (5) . An HCCS E159K substitution is defective in step 1 and results in reduced cyt c biosynthesis in recombinant E. coli, whereas HCCS E159A enhances biosynthesis. Both HCCS E159K and E159A purify with less endogenous heme than wt HCCS and when coexpressed with human cyt c, copurify with less holocyt c. Moreover, certain HCCS mutants that are defective in step 1, including E159K and W162A, are corrected for function (i.e., cyt c biosynthesis) in recombinant E. coli by exogenous aminolevulinic acid, which increases heme synthesis (5) . These data support the proposal that HCCS Glu159 and Trp162 are involved in heme binding and that a balance in heme levels (in vivo), heme binding and release by HCCS all impact holo-cyt c biosynthesis.
Saccharomyces cerevisiae HCCS has been used in recombinant E. coli previously to biosynthesize WT cyt c and selected cyt c variants, such as single thioether (e.g., SXXCH), M81A, and a few other cyt cs (7-9). However, HCCS does not appear to recognize (or at least biosynthesize) single thioether variants where the second cysteine is substituted (e.g., CXXSH) (7). Histidine ligand variants (e.g., CXXCM, bis-Met) have also not been produced, nor does bis-Met or single thioether (CXXXH) exist in nature. In this study, we use human HCCS mutants to show that they release and biosynthesize certain cyt c variants at higher levels than WT HCCS, including a bis-Met cyt c. Results support the proposal that such engineered HCCS mutants are involved in the release step 4. We speculate that weakening the interaction of heme in these HCCS mutants (step 4) Significance Specific mutations in human holocytochrome c synthase (HCCS) confer enhanced biosynthesis of cyt c, including cyt c variants never before produced. These include a bis-Met and single thioether cyt c. We designate these as HCCS "release mutants" because evidence indicates they are mechanistically affected in step 4 of biosynthesis, release of cyt c from the HCCS/cyt c complex. Characteristics of cyt c WT (His/Met), cyt c H19M (bisMet), cyt c M81H (bis-His), and cyt c M81A (His/OH − ) indicate proper folding and that the engineered ligands are present. This panel of variants spans a redox gradient of more than 400 mV, which will be useful for studying various redox-dependent cellular processes and other physical properties.
facilitates release of the cyt c variants from the HCCS enzyme, which resets HCCS for further catalysis (step 1).
Results
Use of HCCS Mutants to Biosynthesize cyt c Variants. Certain HCCS mutants biosynthesize WT cyt c at modestly higher levels (1.5-to 2-fold) than WT HCCS (5). We initially chose two cyt c variants never before biosynthesized that are poorly expressed by WT HCCS, to determine if higher levels could be biosynthesized using selected HCCS mutants (HCCS_E159A, HCCS_N155A, HCCS_W118A). This included the human cyt c bis-Met variant, H19M, and the second thioether variant, C18A. The human cyt c sequence is shown in Fig. S1B (numbering includes initiator methionine). For these preliminary studies, nonhexahistidinetagged cyt c variants were used. Cyt c variants were induced with 0.16% arabinose and HCCS W118A, N155A, or E159A with isopropyl-β-D-thiogalactopyranoside (IPTG) in E. coli deleted of its own cyt c biogenesis pathway (MG1655 Δccm) (10) . Cyt c levels were quantified from 1-L culture supernatants after ion exchange chromatography. For cyt c H19M, HCCS W118A biosynthesized twofold, N155A threefold, and E159A ninefold higher levels than WT HCCS. For the cyt c C18A variant, HCCS W118A yielded 6-fold, N155A 3-fold, and E159A greater than 10-fold higher levels compared with WT HCCS.
We focused on HCCS E159A, constructing a variety of cyt c variants to test, many containing cleavable hexahistidine tags for further purification and analyses. Cyt c variants included both axial ligand and thioether substitutions (Table S1 ). These studies confirmed initial results with the overproduction of cyt c H19M and C18A, in addition to the C18S variant. We chose to analyze cyt c axial ligand variants in detail because a bis-Met cyt c has never been made, thus facilitating a comparison in changes to both axial ligands. Mass spectrometry analyses of intact WT (12,365 Da) had the most abundant peak at 12,232 ± 5 ppm, and the H19M cyt c (12,359 Da) had the most-abundant peak at 12,226 ± 5 ppm. The difference between the calculated values for intact cyt c and cyt c H19M and the measured values is 133 Da, consistent with the cleavage of the initiating Met (131 Da). The 2-Da difference is within the experimental error (Fig. S2 ). The size difference between cyt c WT and H19M is that of a His/ Met substitution with heme covalently attached in both cyt c proteins and no other modifications. We overexpressed and purified four cyt c proteins with cleavable hexahistidine tags and putative axial ligand changes (WT = His/Met, H19M = Met/Met, M81A = His/none, M81H = His/His). Proteins were purified by ion exchange and cobalt column chromatography. The proteins were pure as determined by SDS/PAGE ( Fig. S3 ) and all were monomeric as determined by gel-filtration HPLC (Fig. S4 ).
UV-vis Spectroscopy of cyt c Axial Ligand Variants. Human cyt c showed typical characteristics by UV-vis spectroscopy ( Fig. 2A) , including a 549.5-nm α-peak in the reduced (Fe 2+ ) state and a red shift of the Soret peak upon reduction. The inset in Fig. 2A of the ferric cyt c shows the weak 695-nm band characteristic of the Met ligation. Table S2 shows the peak absorptions observed here compared with those reported in the literature. The spectrum of cyt c M81H (bis-His) was very similar to cyt c ( Fig. 2B ) with the exception that the 695-nm band is absent in the ferric species. To our knowledge, no biosynthesized cyt c M81H variants have been reported, although a chemically synthesized horse heart cyt c M81H exhibits similar spectra (11) . Cyt c M81A spectra (Fig.  2C) show only minor differences between oxidized and reduced forms, with no sharp α-or β-peaks in the reduced state, and a small red shift (3-5 nm) of the Soret upon reduction. The ferrous cyt c M81A biosynthesized here has a Soret peak at 411 nm with a nm.
360 500 600 700 800 nm. shoulder at 434 nm, a peak at 544 nm with a shoulder at 563 nm (Fig. 2C) . Similarly, the ferrous deoxy form of M81A-equivalent iso-1 cyt c from yeast has a Soret of 410 nm with a shoulder at 437 nm and peaks at 548 nm with shoulders at 521 and 564 nm (Table S2 ) (12) . The Soret shoulder has been attributed to a mixture of spin states for the chemically synthesized horse heart cyt c M81A, whereas the absorbance is consistent with His/OH − ligation state (13) . The UV-vis spectrum of our human ferric cyt c M81A closely matches the ferric yeast iso-1 cyt c variant at pH 7.0 (12) .
A spectrum of ferrous cyt c H19M (bis-Met) looks similar to WT cyt c in its defined α and β maxima (549/520 nm), which is indicative of two strong axial ligands (14) . For ferric cyt c H19M, a peak is observed at 597 nm, which indicates a penta-coordinate state with one axial ligand (15) . No absorbance at 597 nm is observed in the presence of excess imidazole (Fig. S5) , consistent with the idea that an open ligand site on heme is now occupied (i.e., the pentacoordinate ferric cyt c H19M is hexacoordinate in the presence of imidazole, suggesting a Met/imidazole ligation of ferric iron). Soret maxima of the reduced (425 nm) and oxidized (398.5 nm) are shifted.
There is a prominent shoulder or doublet (418 nm) in the Soret (425 nm) of ferrous cyt c H19M (Fig. 2D, Inset) . One possible explanation for this doublet is that a heterogeneous population exists with other residues transiently acting as ligands, replacing the methionines. There are two other histidines in cyt c H19M, His-27 and His-34, and these have been discussed previously as forming axial ligand intermediates during folding (16, 17) . We substituted alanines for H27 and H34 in cyt c H19M and WT. No differences were observed in UV-vis spectra of these cyt c variants (Fig. S6 ) and the cyt c H19M/H27A/H34A still exhibited the unique doublet in the Soret region of the reduced protein. We determined if the Soret doublet is caused by a titratable group by recording spectra at various pH values (pH 2.6-6.6) (Fig. S7) . The only change in the doublet observed was correlated with a change in redox state. Another possibility is that there is a mixture of spin states present with the ferrous iron, as we observe in ferric iron in cyt c H19M (see below). We propose that the Soret doublet is a feature of the bisMet ligation state in the reduced protein.
Electron Paramagnetic Resonance Spectroscopy of cyt c Axial Ligand
Variants. Electron paramagnetic resonance (EPR) spectroscopy at 10 K was carried out on the oxidized cyt c proteins to interrogate the ligand coordination and spin states of the ferric center (Fig. 3) . Each cyt c exhibits a distinct EPR spectrum, which supports the argument for axial ligand changes in these variants. EPR g values less than 4 are typically suggestive of low spin heme centers. In addition the EPR spectra each contain signals at g = 2.00 and 2.08 that correspond to organic radical and copper (Cu 2+ ) impurities, respectively, and both signals are marked with an asterisk (*) for all spectra (Fig. 3) (Table S3) , and are reflective of the presence of axial His/Met ligands. The EPR of yeast iso-1 cyt c has been recorded for Met81 variants: Asp, Ala, Cys, Leu, Lys, Ile, and Phe (21, 22) . Of these, yeast iso-1 cyt c M81A shows the most similarity to the human cyt c M81A signals, which exhibit g values at 2.58, 2.18, and 1.86 (Fig. 3) . These peaks are representative of the signals that appear for OH − ligation (21) (Table S3 ). In addition, pronounced peaks are present at 2.08 and 1.97 in human cyt c M81A. These are also observed in the yeast iso-cyt c M81A variant, albeit with weaker intensity (20, 21) . Human cyt c M81H exhibits g values at 2.91, 2.29, and 1.58, very similar to a cytochrome b562 M7H with bisHis ligands to b heme and bis-imidazole-ligated hemin (23) ( Table S3) . We conclude that biosynthesized cyt c M81H has bisHis ligation.
Interestingly, the putative bis-Met cyt c variant H19M shows the simplest EPR spectra in the low-spin region; there is no signal with a g value near 3, which is necessary for low spin heme and so we conclude that cyt c H19M is fully high spin at pH 7.4 (Fig. 3) . The high-spin region however has several well-defined peaks (8.35/7.55/6.70, 5.83/5.38/4.30). We attribute these peaks together with the signal at low g values (1.96/1.85) to be due to at least two different high-spin heme species that exhibit different degrees of rhombicities. The third, most-rhombic set of signals could be because of a third high-spin heme species, or it could be because of nonheme iron in rhombic coordination (21) . These high-spin heme species could have a single Met binding to the iron center and water binding at the opposite axial site. Such a conformation is consistent with the UV-vis ferric cyt c H19M spectrum that we observe. When cyt b562 axial ligand His102 is changed to methionine, a nearly identical, low-spin signal at 1.98 is exhibited at pH 9.2 (Table S3) (24) . Thus, we conclude that the cyt c H19M variant possesses Met ligation.
The EPR spectra (Fig. 3) suggest that the least heterogeneity is observed in cyt c M81H with only a low-spin species present and a single main set of g x , g y , and g z values. This finding is not surprising because histidine provides the strongest bond to the heme iron center in the proper geometry.
Circular Dichroism Spectroscopy and Thermal Stability of cyt c Axial Ligand Variants. Circular dichroism (CD) spectra in the far UV region provides an indication of α-helical composition. CD spectra between 200 and 260 nm of all four cyt c's were identical (Fig. 4A) , suggesting that each is folded generally with the same α-helical content. By monitoring secondary structure at 220 nm with temperature increases (Fig. 4B) , it is observed that each of the four different axial ligand cyt c proteins exhibit a Tm of 90°C. This is in contrast to the cyt c single thioether variants (C15S and C18S), which show significant changes in stability (Fig. 4B) . We conclude that regardless of axial ligand changes in cyt c, stability and secondary structure are retained, thus likely folding into its native structure.
CD spectra in the near UV Soret region (300-450 nm) probe the immediate heme environment, for example vinyl groups redshift absorbance and propionates enhance absorption in reconstituted myoglobins (25) . Near UV-vis CD spectra of reduced (Fig. 4C) and oxidized (Fig. 4D ) cyt c proteins show very different absorbance features for each ligand variant, unlike the spectra of WT cyt c from different species (26 Fig. 3 . The EPR spectra of the oxidized cyt c variants shows that iron is present in different protein environments. An asterisk (*) denotes signal at g = 2.00 or 2.08, which correspond to organic radical or Cu impurities.
significantly altered in both positive and negative maxima. In the ferric form of cyt c, it has been shown through denaturation with alcohols or binding cardiolipin that the negative ellipticity at 417 nm is a result of Met81 ligation to heme (27, 28) . Consistent with this conclusion, cyt c M81A and M81H do not exhibit this negative ellipticity (Fig. 4D) . Cyt c H19M also does not exhibit a negative ellipticity at 417 nM, which might be because of the lack of an Met19 ligand or that Met81 is partially released in the ferric form, as suggested by imidazole effects noted above. CD experiments in the near UV region with oxidized and reduced undecapeptide cyt c showed that in the presence of imidazole a bis-His ligation occurs with a peak at 411 nm (29) , like the oxidized and reduced cyt c M81H recorded here (Fig. 4 C and D) . The results support conclusions from EPR and UV-vis spectra that each cyt c variant has significant ligand differences.
Oxidation/Reduction Potentials of cyt c Axial Ligand Variants. Mitochondrial cyt c possesses a redox potential of +250 mV, higher than donor cyt bc 1 but lower than acceptor cyt a/a 3 . Axial ligand composition is a major factor in the redox potential of a heme or metal protein (30, 31) . We determined the redox potentials of the four cyt c proteins ( Fig. 5 ; for individual spectra see Fig. S8 ). As expected, the human WT cyt c shows a potential of +252 mV vs. standard hydrogen. The redox potential for cyt c M81A (−19 mV) was over 270-mV more negative than WT cyt c. A similar potential was determined previously for yeast iso-1-cyt c M80A (−80 mV) (20) . The potential of cyt c M81H (−69 mV) suggests a stabilization of the oxidized cytochrome, similar to the chemically generated horse heart bis-His cyt c variant (+41 mV) (11) ; such a change is often observed when substituting a stronger histidine ligand for methionine. Conversely, substituting a methionine for a histidine ligand is predicted to increase the potential and this is what is observed for cyt c H19M (+349 mV), increasing 100 mV over WT cyt c (+252 mV). For individual spectra of cyt c H19M at each potential (Fig. S8B) , we observed that the Soret doublet is maintained throughout the titration but only in the reduced state. This finding again suggests that the doublet is caused by the heme environment and not by the heterogeneity of the ligand state. Discussion HCCS Release Mutants. We show that substitutions engineered in conserved residues of HCCS can lead to significant biosynthetic overproduction of unique cyt c variants in recombinant E. coli. We discuss below how these mutations impact the release step 4 for each cyt c variant. We thus term these HCCS "release mutants." If HCCS release mutants make as much or more cyt c than WT HCCS, the question arises as to why these residues are conserved in HCCS (Fig. S1A) . We suggest that these residues are necessary for binding heme in step 1 at concentrations of heme present within the mitochondrial intermembrane space. Multiple residues contribute to the heme binding site of HCCS, including heme iron ligand His154 and Glu159, Asn155, and Trp162, all within domain II of HCCS (5) . Our data support the hypothesis that in recombinant E. coli release of holocyt c from HCCS can be increased and release may be a limiting step. We have not tested whether under heme limiting conditions (e.g., iron limitation) the HCCS release mutants become defective in step 1. However, certain release mutants (e.g., W118A) biosynthesize even more WT cyt c when heme precursor aminolevulinic acid is added to the culture (5) . These data indicate that modulating heme levels as well as using engineered HCCS enzymes can augment biosynthesis. The steps for which each HCCS variant is impacted will depend on the heme levels and potentially other factors in the cell.
Mechanisms of Biosynthesis by HCCS. The bacterial system I and II cytochrome c biogenesis pathways are more complex and appear to recognize only the CXXCH motif; thus, no one has engineered them to biosynthesize, for example, bis-Met or single thioether c-type cytochromes. The mitochondrial HCCS, on the other hand, recognizes an extended region besides the CXXCH motif, including α-helix 1 immediately preceding CXXCH (32, 33) . Recognition of this extended region may help in making new c-type cytochromes with substitutions in CXXCH. We showed previously the importance of cyt c His19 (of CXXCH) in forming the second axial ligand of the HCCS/cyt c complex, with HCCS His154 providing the first ligand (Fig. 1, step 2) (4, 6) . Only methionine could substitute for cyt c His19, whereby Met19 facilitated preparation of the heme for covalent attachment (6) . However, the cyt c H19M variant was "trapped" in the WT HCCS complex with very low release. We proposed that another role for His19 is to "pull" heme from the HCCS active site. Using HCCS release mutants in putative heme binding residues, we show here that more cyt c H19M is released and biosynthesized. This result is consistent with the hypothesis that HCCS must dissociate from heme (as holocyt c) in its mechanism, and it has evolved a balance in binding (step 1) and release (step 4). Although cyt c Met19 is not as strong at "pulling" heme from HCCS, use of the HCCS release mutants counteract this limitation in the biosynthesis of cyt c H19M.
HCCS release mutants also facilitate overproduction of certain cyt c single thioether variants. The cyt c C15S variant has been biosynthesized previously at levels about 10% of WT cyt c, using the yeast HCCS (7) or the human HCCS (4). This finding is not too surprising because such single thioether cyt c's (XXXCH) naturally exist in Euglenozoa. Resonance Raman spectroscopy of complexes containing WT HCCS and copurified cyt c C15 and C18 variants has provided a possible explanation (6) . In the complex with the cyt c C15 variant (thioether attached at C18), the heme is more distorted (puckered) than the complex with the cyt c C18 variant (thioether attached to C15) (6) . We speculated that optimal heme distortion is needed for release from HCCS, thus much less cyt c C18S variant is released (less than 3% than that of WT cyt c). This hypothesis is supported by results herein, whereby HCCS release mutants increase synthesis of cyt c C18 variants up to ninefold over WT HCCS (Table  S1 ), allowing for biosynthesis of this unique single thioether cyt c. In this case (C18 variants), release from HCCS is suboptimal because of less heme distortion, thus stronger retention of heme (holo-cyt c). Again, weakening the interaction with heme via the HCCS mutations counteracts this defective release.
It is informative that the two cyt c variants with defective release properties (cyt c H19M and C18A/S) are impacted the most by the use of HCCS release mutations. In this regard, HCCS release mutants appear to have the least effect on overproduction of cyt c M81 substitutions, generally providing yields similar to WT HCCS (Table S1 ). Cyt c M81 is proposed to play a role after HCCSmediated covalent attachment of heme and release, thus after folding begins (Fig. 1) . Possibly, this finding explains why HCCS E159A does not impact production levels of at least cyt c M81A and M81H.
The cyt c Variants Biosynthesized in This Study. We describe biophysical properties of the set of cyt c proteins with axial ligand differences (His/Met, Met/Met, Met/OH − , His/His), including redox potentials, UV-vis, EPR, and CD analyses, all of which support the axial ligand changes that were engineered. We found that ferric cyt c H19M is largely pentacoordinate based on the UV-vis data, together with the addition of imidazole and mostly high-spin species (EPR), whereas the ferrous cyt c H19M is hexacoordinate based on UV-vis. Ferrous cyt c H19M may also have a mixture of spin states that may explain the doublet in the Soret. For cyt c H19M, this ligation state stabilizes the ferrous iron in heme and increases the redox potential by ∼100 mV. Studies on denaturation of ferrous cyt c have generally agreed that His-19 ligation is extremely stable even under severe conditions (e.g., low pH, guanidine HCl) (34, 35) . From this and other studies, one could conclude that the proximal side with His-19 heme ligation is an important initial step in folding. With regards to the involvement of cyt c His-19 on folding, biosynthesis of cyt c H19M by HCCS suggests that the histidine of CXXCH does not play an essential role in folding at least toward the final native structure. Our results suggest that HCCS release mutants still allow for proper stereochemistry and folding of cyt c WT and variants. Future studies using these variants include continued analysis of unique structural and physical properties, folding kinetics and pathways, as well as their potential interactions in apoptosome formation.
Materials and Methods
Strains and Plasmids and Their Generation. The E. coli strain, RK103 (MG1655 Δccm) (10) was cotransformed with a pGEX plasmid (carb R ) containing the human HCCS gene [e.g., pRGK403 (4), HCCS_E159A, HCCS_W118A, HCCS_N155A] (5) and a pBAD plasmid with a human cyt c gene (listed in Fig.  S9 ). Mutations were introduced into the pBAD plasmid using site-directed mutagenesis as has been described previously (36) .
Bacterial Growth Conditions, Protein Expression, and Purification. E. coli strains were grown as previously described (4) and the proteins were expressed overnight. Cyt c was isolated as described previously (6) . Cyt c variants, were purified over 5 mL HiTrap SP-Sepharose. The column was washed with 50 mL of 50 mM Tris pH 8.0 (0 mM, 50 mM, and 75 mM NaCl). The pink cyt c was eluted with excess 50 mM Tris pH 8.0, 100 mM NaCl. Cyt c variants with C-terminal cleavable (thrombin cut site, LVPRjGS) hexa histadine tags were purified over SP-Sepharose resin followed by HisPur cobalt resin (ThermoFisher Scientific). The cyt c was eluted from the SP-Sepharose with 50 mM phosphate pH 7.4, 10 mM imidazole, 300 mM NaCl. The eluate was loaded onto 500 μL HisPur Cobalt Resin Slurry, washed with 10-column volumes of wash buffer (50 mM phosphate 7.4, 10 mM imidazole, 300 mM NaCl), and eluted in 50 mM phosphate pH 7.4, 150 mM imidazole, 300 mM NaCl. Excess thrombin was added to the eluate and dialyzed in 8-kD BioDesignDialysis Tubing (ThermoFisher Scientific) overnight at 4°C in 50 mM Tris ph 8.0, 500 mM NaCl, and 10% (vol/vol) glycerol. The cleaved cytochromes were separated from thrombin and uncleaved product by passage over a mixed HisPur/Benzamidine Sepharose column (GE Healthcare Life Sciences). The cyt c was buffer exchanged and concentrated using a Vivaspin Turbo 3-kD centrifugal concentrator (ThermoFisher Scientific).
UV-vis Spectroscopy. UV-vis spectroscopy was recorded on a Shimadzu UV-1800 spectrophotometer at room temperature in 50 mM phosphate buffer pH 7.4. Reduced spectra were recorded with excess sodium dithionite (sodium hydrosulfate). Oxidized spectra were recorded in the presence of excess ammonium persulfate. EPR Spectroscopy. EPR was performed using a Bruker EMX-PLUS (9.2 GHz) EPR spectrometer at 10 K with quartz sample tubes. Samples were oxidized with excess K 3 [Fe(CN) 6 ] and then desalted with a G25 column (9) .The protein sample was concentrated to 3.6 mg/mL in 50:50 (vol/vol) 100 mM sodium phosphate buffer pH 7.4 and glycerol. Four 4-min scans were accumulated and averaged, and the following parameters were used during the collection of the EPR spectra: attenuation, 33 dB; time constant, 0.2 s; modulation amplitude, 1 mT; sweep width, 500 mT; frequency, 9371.852 MHz; power, 0.1 mW.
CD Spectroscopy and Thermal Stability. Equilibrium samples were recorded on a Jasco J-815 at room temperature in 50 mM phosphate buffer pH7.4, 50 mM NaC. The machine sensitivity was 100 mdeg, the data pitch was 0.5 nm, the scanning mode was continuous, the scanning speed was 50 nm/min, the response rate 0.5 s for far-UV and 1 s for near-UV, the bandwidth 1 nm, and five accumulations were taken. Thermal stability samples of cyt c variants was determined by recording the ellipticity at 220 nm. Temperature was incremented at 0.5°C/min, absorbance was detected with standard sensitivity, 8-s response time, and a 1-nm bandwidth.
Redox Titrations. Spectroelectrochemistry was performed using a CHI620C CH Instruments potentiostat and a Shimadzu UV-1800 spectrophotometer as described previously (37) . Measurements were carried out in 50 mM sodium phosphate buffer (pH 7.0) and 50 mM NaCl. 20 μM each of 4,4-dipyridyl (E o = −0.84 V) (38) and hexamine ruthenium (III) chloride (E o = −0.44 V) were included to mediate electron transfer between the honeycomb and protein in the titrations of cyt c M81A and cyt c M81H.
Additional methods are described in SI Materials and Methods.
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